Association between treatment resistance and cognitive function in schizophrenia
Introduction: Treatment-resistant schizophrenia (TRS) affects around 30% of individuals with schizophrenia. About half of the patients with TRS who are treated with clozapine do not show a meaningful clinical response, that is, clozapine resistance. To date, the relationship between cognitive functi...
Saved in:
Main Authors: | Jiaqian Sun, Jie Yin Yee, Yuen Mei See, Charmaine Tang, Shushan Zheng, Boon Tat Ng, Jimmy Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer – Medknow Publications
2024-10-01
|
Series: | Singapore Medical Journal |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/singaporemedj.SMJ-2024-143 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Relation of Vitamin D levels with positive and negative symptoms of schizophrenia – A hospital based cross-sectional comparative study
by: Soumitra Ghosh, et al.
Published: (2023-09-01) -
Disability and quality of life in patients with treatment-resistant schizophrenia on long- term clozapine therapy
by: Dhandapani Nandakumar, et al.
Published: (2023-06-01) -
The time has come for revising the rules of clozapine blood monitoring in Europe. A joint expert statement from the European Clozapine Task Force
by: Hélène Verdoux, et al.
Published: (2025-01-01) -
Prevalence of obsessive-compulsive symptoms in patients with schizophrenia treated with clozapine: a scoping review
by: Evelyn Moreno Tarazona, et al.
Published: (2025-01-01) -
Treatment of a schizophrenia patient on long-term super-dose antipsychotics: a case report
by: Xiaobo Xie, et al.
Published: (2025-01-01)